Molecular characterization and antimicrobial susceptibility of extended-spectrum β-lactamase-producing Enterobacteriaceae isolates at a tertiary-care centre in Monterrey, Mexico

Journal of Medical Microbiology

Volumn 60, Issue 1, 2011, Pages 84-90

  Garza González, Elvira ^a   Ibarra, Sandra Iveth Mendoza ^a   Llaca Díaz, Jorge M ^b   Gonzalez, Gloria M ^a  

^a Medicina UANL   (Mexico)

^b HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; BETA LACTAMASE CTX M; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; EXTENDED SPECTRUM BETA LACTAMASE; LEVOFLOXACIN; PIPERACILLIN; TIGECYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; ENTEROBACTER CLOACAE; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENOTYPE; HOSPITAL; KLEBSIELLA PNEUMONIAE; MEXICO; PHENOTYPE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SERRATIA MARCESCENS; TERTIARY HEALTH CARE;

EID: 78650812507     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.022970-0     Document Type: Article

References (27)

1. Alcantar-Curiel, D., Tinoco, J., Gayosso, C., Carlos, A., Daza, C., Perez-Prado, M., Salcido, L., Santos, J. & Alpuche-Aranda, C. (2004). Nosocomial bacteremia and urinary tract infections caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae with plasmids carrying both SHV-5 and TLA-1 genes. Clin Infect Dis 38, 1067-1074.
2. Al-Obeid, S., Bremont, S., Jabri, L., Massoudi, N. & Haddad, Q. (2008). Klebsiella pneumoniae LO10 producing extended-spectrum β-lactamase SHV-12 in Saudi Arabia. J Chemother 20, 709-713.
3. Baraniak, A., Fiett, J., Hryniewicz, W., Nordmann, P. & Gniadkowski, M. (2002). Ceftazidime-hydrolysing CTX-M-15 extended-spectrum β-lactamase (ESBL) in Poland. J Antimicrob Chemother 50, 393-396.
4. TLA-1 with a novel ISCR element, ISCR20. Antimicrob Agents Chemother 54, 4026-4028.
5. Bonnet, R. (2004). Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48, 1-14.
6. Bradford, P. A. (2001). Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14, 933-951.
7. Cantón, R., Novais, A., Valverde, A., Machado, E., Peixe, L., Baquero, F. & Coque, T. (2008). Prevalence and spread of extended-spectrum β-lactamase- producing Enterobacteriaceae in Europe. Clin Microbiol Infect 14 (Suppl. 1), 144-153.
8. CLSI (2009). Performance Standards for Antimicrobial Susceptibility Testing, 19th informational supplement, M100-S19. Wayne, PA: Clinical and Laboratory Standards Institute.
9. Coque, T. M., Oliver, A., Pérez-Díaz, J. C., Baquero, F. & Cantón, R. (2002). Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum β-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000). Antimicrob Agents Chemother 46, 500-510.
10. Du Bois, S. K., Marriott, M. S. & Amyes, S. G. (1995). TEM- and SHV-derived extended-spectrum β-lactamases: relationship between selection, structure and function. J Antimicrob Chemother 35, 7-22.
11. Espinosa de los Monteros, L. E., Silva-Sanchez, J., Jiménez, L. V., Rojas, T., Garza-Ramos, U. & Valverde, V. (2008). Outbreak of infection by extended-spectrum β-lactamase SHV-5-producing Serratia marcescens in a Mexican hospital. J Chemother 20, 586-592.
12. SHV-5 gene is encoded in a compound transposon duplicated in tandem in Enterobacter cloacae. Clin Microbiol Infect 15, 878-880.
13. Kiratisin, P., Apisarnthanarak, A., Laesripa, C. & Saifon, P. (2008). Molecular characterization and epidemiology of extended-spectrum β- lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother 52, 2818-2824.
14. Miranda, G., Castro, N., Leaños, B., Valenzuela, A., Garza-Ramos, U., Rojas, T., Solórzano, F., Chihu, L. & Silva, J. (2004). Clonal and horizontal dissemination of Klebsiella pneumoniae expressing SHV-5 extended-spectrum β-lactamase in a Mexican pediatric hospital. J Clin Microbiol 42, 30-35.
15. Murray, P. R., Baron, J. L., Jorgensen, J. H., Landry, M. L. & Pfaller, M. A. (2007). Manual of Clinical Microbiology, 9th edn, vol. 1. Washington, DC: American Society for Microbiology.
16. Paterson, D. L. & Bonomo, R. A. (2005). Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 18, 657-686.
17. Poirel, L., Naas, T., Le Thomas, I., Karim, A., Bingen, E. & Nordmann, P. (2001). CTX-M-type extended-spectrum b-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop. Antimicrob Agents Chemother 45, 3355-3361.
18. Poirel, L., Gniadkowski, M. & Nordmann, P. (2002). Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum β-lactamase CTX-M-15 and of its structurally related β-lactamase CTX-M-3. J Antimicrob Chemother 50, 1031-1034.
19. Rocha-Gracia, R., Ruiz, E., Romero-Romero, S., Lozano-Zarain, P., Somalo, S., Palacios-Hernández, J., Caballero-Torres, P. & Torres, C. (2010). Detection of the plasmid-borne quinolone resistance determinant qepA1 in a CTX-M-15-producing Escherichia coli strain from Mexico. J Antimicrob Chemother 65, 169-171.
20. Rotimi, V. O., Jamal, W., Pal, T., Sovenned, A. & Albert, M. J. (2008). Emergence of CTX-M-15 type extended-spectrum β-lactamase-producing Salmonella spp. in Kuwait and the United Arab Emirates. J Med Microbiol 57, 881-886.
21. Severin, J. A., Mertaniasih, N. M., Kuntaman, K., Lestari, E. S., Purwanta, M., Lemmens-Den Toom, N., Duerink, D. O., Hadi, U., van Belkum, A. & other authors (2010). Molecular characterization of extended-spectrum β-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia. J Antimicrob Chemother 65, 465-469.
22. Silva, J., Aguilar, C., Ayala, G., Estrada, M., Garza-Ramos, U., Lara- Lemus, R. & Ledezma, L. (2000). TLA-1: a new plasmid-mediated extended-spectrum β-lactamase from Escherichia coli. Antimicrob Agents Chemother 44, 997-1003.
23. Singh, A., Goering, R., Simjee, S., Foley, S. & Zervos, M. (2006). Application of molecular techniques to the study of hospital infection. Clin Microbiol Rev 19, 512-530.
24. Siu, L. K., Lu, P.-L., Hsueh, P.-R., Lin, F. M., Chang, S.-C., Luh, K.-T., Ho, M. & Lee, C.-Y. (1999). Bacteremia due to extended-spectrum β-lactamase- producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes. J Clin Microbiol 37, 4020-4027.
25. Tansawai, U., Boonkerd, N., Polwichai, P., Dejsirilert, S. & Niumsup, P. (2009). SHV-12 extended spectrum b-lactamase associated with high-level ceftazidime resistance in Enterobacter cloacae isolated from Thailand. Southeast Asian J Trop Med Public Health 40, 148-154.
26. Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H. & Swaminathan, B. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33, 2233-2239.
27. Yu, W. L., Pfaller, M. A., Winokur, P. L. & Jones, R. N. (2002). Cefepime MIC as a predictor of the extended-spectrum β-lactamase type in Klebsiella pneumoniae, Taiwan. Emerg Infect Dis 8, 522-524.